Press release
Interventional Radiology Industry Trends, Business Strategies, Regional Outlook and Future Analysis
A number of factors such as the growing prevalence of chronic diseases, soaring popularity of minimally invasive procedures, rising geriatric population, soaring number of R&D activities, and ongoing technological advancements will accelerate the interventional radiology market at 6.4% CAGR during 2019-2024. According to P&S Intelligence, the market will generate $27.3 billion revenue by 2024. Moreover, the increased reimbursement rate for interventional radiology procedures will also contribute to the market growth in the coming years.The rising incidence of chronic diseases is one of the primary growth drivers of the market. The American Institute for Cancer Research stated that 18.1 million new cases of cancer were diagnosed around the world in 2020. Of these, 8.8 million patients were women and 9.3 million were men. The research institute also estimated that 550,000 new cases of bladder cancer were recorded in 2018. Moreover, the WHO states that more than 55 million people are currently living with dementia worldwide.
Download sample pages of this report: https://www.psmarketresearch.com/market-analysis/interventional-radiology-market/report-sample
In the recent past, the angioplasty category accounted for the largest share in the interventional radiology market, within the procedure segment. The dominance of this category can be primarily credited to the growing prevalence of CVDs. Approximately 17.9 million human lives were lost due to CVDs in 2019, accounting for nearly 32% of all global deaths, as per the WHO. The organization also states that 17 million premature deaths were caused due to NCDs, 38% of which were caused by CVDs.
Currently, the interventional radiology market is characterized by the presence of numerous large players, such as Canon Medical Systems Corporation, Carestream Health Inc., Hitachi Ltd., Hologic Inc., Siemens AG, Esaote S.p.A, Shimadzu Corporation, Samsung Electronics Co. Ltd., and Koninklijke Philips N.V. Nowadays, market players are extensively focusing on product launches and marketing approvals to gain a competitive edge. For example, in March 2018, GE Healthcare announced the commercial launch of the LOGIQ E10 ultrasound system to improve the patient experience.
Globally, the North American interventional radiology market generated the highest revenue in the preceding years, and it will continue this trend in the coming years as well. This can be credited to the presence of advanced healthcare facilities and huge healthcare expenditure in the region. According to the Centers for Medicare and Medicaid Services, the national healthcare expenditure of the U.S. stood at $4.1 trillion in 2020, wherein Medicare spending and Medicaid spending of the country was $829.5 billion and $671.2 billion, respectively, in 2020.
Make inquiry before purchase of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=interventional-radiology-market
Whereas, the APAC interventional radiology market is expected to witness the fastest growth in the foreseeable future, owing to the increasing burden of chronic diseases, improving healthcare expenditure, growing healthcare spending, and burgeoning geriatric population. According to the WHO, the Southeast Asian region is observing a high burden of cancer, CVDs, chronic respiratory diseases, and diabetes. It also states that these diseases account for 8.5 million deaths in Southeast Asian countries each year.
Thus, the rising incidence of chronic illnesses will propel the market growth in the upcoming years.
Browse more reports:
MRI Systems Market - https://www.psmarketresearch.com/press-release/global-magnetic-resonance-imaging-market
Computed Tomography Market - https://www.psmarketresearch.com/press-release/computed-tomography-market
Contact:
P&S Intelligence
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: https://healthcarefuturetrends.blogspot.com
About P&S Intelligence
P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Interventional Radiology Industry Trends, Business Strategies, Regional Outlook and Future Analysis here
News-ID: 2981169 • Views: …
More Releases from P&S Intelligence

U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period.
According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven…

Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period.
This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.…

Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,…

Competitive Landscape of the Industrial Starches Market: Key Players, Trends, an …
According to the latest market research study published by P&S Intelligence, the global industrial starches market is poised for significant growth, with a projected increase from USD 110.3 billion in 2024 to USD 169.9 billion by 2030, at a robust compound annual growth rate (CAGR) of 7.5%. Industrial starches play a crucial role in diverse sectors, including food, pharmaceuticals, and paper, driven by their unique properties such as stabilizing, thickening,…
More Releases for CVDs
Global Cardiovascular Diagnostic & Monitoring Devices Market to Reach Over USD 2 …
The global cardiovascular diagnostic & monitoring devices market, valued at USD 14.2 billion in 2021, is projected to nearly double to over USD 29.0 billion by the end of 2031, expanding at a robust CAGR of 7.5% over the forecast period (2022-2031). Fueled by the surging burden of chronic cardiovascular diseases (CVDs), demand for early diagnosis, and rapid technological advancements including AI‐enabled monitors and minimally invasive implants the market presents…
Contrast Enhanced Ultrasound Market by Product (Equipment, Nanoparticle & Molecu …
"The contrast-enhanced ultrasound market is projected to grow at a CAGR of 6.1% during the forecast period (2023-2028)."
The global contrast-enhanced ultrasound market is projected to reach USD 2.1 billion by 2028 from USD 1.6 billion in 2023, at a CAGR of 6.1% from 2023 to 2028. Factors such as rising geriatric population and increasing use of contrast agents are responsible for the increasing growth of this market. Increasing research and…
RAS-acting Agents Market to Reach US$ 13.4 Billion by 2031 Due to Increase in pr …
The global 𝗥𝗔𝗦-𝗮𝗰𝘁𝗶𝗻𝗴 𝗔𝗴𝗲𝗻𝘁𝘀 market is estimated to attain a valuation of US$ 13.4 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 4.2% during the forecast period, 2023-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of…
Ventricular Assist Devices Market to Reach US$ 2.80 Billion by 2027, Fueled by R …
According to the latest report by IMARC Group, titled "Ventricular Assist Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global ventricular assist devices market reached a value of US$ 1.56 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.80 Billion by 2027, exhibiting at a CAGR of 10.09% during 2022-2027. A ventricular assist device (VAD), also called a mechanical circulatory…
Rising Prevalence of CVDs Leads to Increasing Demand for Cardiac Biomarkers
In 2021, the cardiac biomarkers industry contributes $8,459.6 million, and it is projected to rise at a rate of 10.5%, to capture $20,718.8 million revenue in 2030. It is led by the rising prevalence of acute coronary syndrome, increasing point-of-care testing kit demand, and technological advancements in the industry.
Moreover, the surging investments in biomarker research, increasing CVDs incidences, and rising geriatric population are projected to boost the industry growth.…
Global rise in the incidence and prevalence rate of cardiovascular diseases (CVD …
Global Cardiovascular Information Systems (Cvis) Market is projected to grow at a considerable growth rate owing to increasing prevalence of CVDs across the globe. According to WHO, in 2018, CVDs accounts for 17.7 million mortality per year, which means 31% mortalities across the globe. The CVIS systems support in the assessment of chronic conditions such as CHD (coronary heart disease), stroke, and other heart related disease. CVIS systems allow assembling…